Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

World News: 13:45 GMT Wednesday 7th February 2018. [Abeona Therapeutics Inc. via Globe Newswire via SPi World News]

• SPi News Home
• Latest News
• News for 2018-02-07
• Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

NEW YORK and CLEVELAND Feb 07 2018 GLOBE NEWSWIRE -- Abeona Therapeutics Inc NASDAQABEO a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, to day rep...

More news and information about Abeona Therapeutics Inc.

Published By:

Globe Newswire: 13:45 GMT Wednesday 7th February 2018

Published: 2018-02-07T13:45:00.

Search for other references to "abeona" on SPi News